Alessandro Iannaccone Email and Phone Number
Alessandro Iannaccone work email
- Valid
- Valid
- Valid
- Valid
Alessandro Iannaccone personal email
Alessandro Iannaccone phone numbers
“Driven, Energetic, Passionate, Committed, Experienced Leader in Retinal Degenerations” Specialties: Retinal degenerationsInherited retinal diseases (IRDs)Autoimmune retinopathyMacular degenerationVisual electrophysiology & psychophysicsClinical TrialsClinical researchTranslational retinal disease researchOphthalmic geneticsEpidemiology and biostatisticsAutoimmunityFundraisingCommunity leadershipVolunteering
Astellas Pharma Us
View- Website:
- northcarolina.edu
-
Global Medical Lead, Cell And Gene Therapy, OphthalmologyAstellas Pharma UsDurham, Nc, Us
-
ProfessorUniversity Of North Carolina At Chapel Hill Apr 2024 - PresentChapel Hill, Nc, Us -
Global Medical Lead, Cell And Gene Therapy, Biopharma And Ophthalmology DivisionAstellas Pharma May 2023 - Present -
ConsultantGuidepoint Oct 2018 - PresentNew York, Ny, UsKOL Consultant providing expert opinion to investors on treatment approaches being developed for retinal dystrophies and degenerations -
ConsultantAdvance Medical, Inc. Jan 2016 - PresentProvide expert clinical review of complex medical retinal cases, with special emphasis on retinal/macular dystrophies and/or degenerations and other rare such disorders
-
ConsultantGlg (Gerson Lehrman Group) May 2015 - PresentNew York, Ny, UsKey Opinion Leader (KOL) Consultant providing expert opinion to investors on treatment approaches being developed for retinal dystrophies and degenerations -
ConsultantClearview Healthcare Partners Mar 2015 - PresentNewton, Ma, UsKey Opinion Leader (KOL) -- provide expert opinion to investors on treatment approaches being developed for retinal dystrophies and degenerations -
Scientific Advisory Board MemberEluminex Biosciences Limited Mar 2022 - May 2023Suzhou, Cn -
ConsultantThe Janssen Pharmaceutical Companies Of Johnson & Johnson Sep 2020 - May 2023Raritan, New Jersey, Us– US Clinical Advisory Board Member for X-linked Retinitis Pigmentosa – KOL Consultant for Janssen IRD Educational Series -
Scientific Advisory Board MemberAlia Therapeutics Jul 2019 - May 2023Trento, Trentino-Alto Adige, ItHelping develop novel gene therapy approaches for inherited retinal diseases -
ConsultantIqvia Jan 2019 - May 2023Durham, North Carolina, UsKOL Consultant on clinical trials for inherited retinal disorders -
Educational ConsultantRhythm Pharmaceuticals Inc. Jan 2019 - May 2023Boston, Ma, UsKOL Consultant about novel obesity therapies for retinal degeneration – obesity syndromes (e.g., Bardet-Biedl and Alström) -
ProfessorDuke University Health System Sep 2016 - May 2023Durham, North Carolina, UsI am delighted to have been offered this important new role at prestigious Duke University, where I look forward to resuming my patient care, clinical research and translational research focus on retinal degenerative diseases and other hereditary diseases of the retina and optic nerve. In addition to my traditional "bread and butter" of retinitis pigmentosa, cone-rod dystrophies, Stargardt disease, Usher syndrome, Bardet-Biedl syndrome, retinoschisis, choroideremia, achromatopsia and blue cone monochromacy to name a few, I will also continue my more recent work on age-related macular degeneration and autoimmune retinopathies and optic neuropathies. We are actively working to bring clinical studies and trials (gene therapy and not only) to Duke in the very near future. I look forward to continuing to seeing my Mid-South patients here, as well as seeing new patients from the Carolinas and the South-East US! -
Medical ConsultantBiogen Feb 2022 - Jan 2023Cambridge, Ma, UsGene-specific and gene-agnostic therapeutic approaches for Inherited Retinal Diseases (IRDs) -
ConsultantGyroscope Therapeutics Mar 2019 - Feb 2020Key Opinion Leader (KOL) Consultant on parasurgical approaches to clinical trials for inherited retinal disorders
-
ConsultantEditas Medicine Jan 2019 - Jan 2020Cambridge, Massachusetts, UsKOL Consultant on therapeutic approaches for inherited retinal disorders -
ConsultantRoivant Sciences Nov 2018 - Sep 2019New York, New York, UsKOL Consultant on novel therapies for inherited retinal disorders -
ConsultantAstellas Research Institute Of America Llc Oct 2018 - Sep 2019KOL Consultant on novel treatments for inherited retinal disorders
-
ConsultantIonis Pharmaceuticals, Inc. Apr 2016 - Dec 2017Carlsbad, Ca, UsKOL Consultant on clinical and pre-clinical development of therapies for retinitis pigmentosa, including various imaging, efficacy and safety endpoints assessments -
ConsultantMetamedica Feb 2014 - Dec 2017Ophthalmic Clinical Consultant, Retinal Degenerations and Ophthalmic Genetics
-
ConsultantHuron Consulting Group Nov 2015 - Nov 2017Chicago, Il, UsKey Opinion Leader (KOL) Consultant -- provide expert opinion to the Life Sciences division for investors on treatment approaches being developed for retinal dystrophies and degenerations -
Associate ProfessorThe University Of Tennessee Health Science Center Sep 2004 - Dec 2015Memphis, Tennessee, UsFounding Director, Retinal Degenerations & Ophthalmic Genetics Service andLions' Visual Function Diagnostic Laboratory -
Assistant ProfessorUniversity Of Tennessee-Health Science Center College Of Medicine Sep 1998 - Jun 2004Memphis, Tennessee, UsFounding Director, Retinal Degenerations & Ophthalmic Genetics Service andLions' Visual Function Diagnostic Laboratory
Alessandro Iannaccone Skills
Alessandro Iannaccone Education Details
-
Sapienza Università Di RomaResidency In Ophthalmology -
The University Of Tennessee Health Science CenterEpidemiology And Biostatistics
-
University Of Tennessee-Health Science Center College Of MedicinePediatric Retinal And Optic Nerve Diseases
-
University Of Pennsylvania School Of MedicinePost-Doctoral Research Fellow
-
Sapienza Università Di RomaMedicine
Frequently Asked Questions about Alessandro Iannaccone
What company does Alessandro Iannaccone work for?
Alessandro Iannaccone works for Astellas Pharma Us
What is Alessandro Iannaccone's role at the current company?
Alessandro Iannaccone's current role is Global Medical Lead, Cell and Gene Therapy, Ophthalmology.
What is Alessandro Iannaccone's email address?
Alessandro Iannaccone's email address is al****@****uke.edu
What is Alessandro Iannaccone's direct phone number?
Alessandro Iannaccone's direct phone number is +190144*****
What schools did Alessandro Iannaccone attend?
Alessandro Iannaccone attended Sapienza Università Di Roma, The University Of Tennessee Health Science Center, University Of Tennessee-Health Science Center College Of Medicine, University Of Pennsylvania School Of Medicine, Sapienza Università Di Roma.
What are some of Alessandro Iannaccone's interests?
Alessandro Iannaccone has interest in Health.
What skills is Alessandro Iannaccone known for?
Alessandro Iannaccone has skills like Clinical Research, Electrophysiology, Clinical Trials, Genetics, Translational Research, Biostatistics, Science, Medical Education, Epidemiology, Animal Models, Fundraising, Neuroscience.
Who are Alessandro Iannaccone's colleagues?
Alessandro Iannaccone's colleagues are Dean Riddick, Allison Carron, Chloe J. Walker, Ph.d, Allison Schindler, Sarah Linnstaedt, Seth Newbury, Alan Johnson.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial